Silk Road Medical, Inc. Common Stock
SILK
SILK was delisted on the 16th of September, 2024.
154 hedge funds and large institutions have $1.5B invested in Silk Road Medical, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 63 increasing their positions, 52 reducing their positions, and 19 closing their positions.
902% more call options, than puts
Call options by funds: $6.24M | Put options by funds: $622K
21% more repeat investments, than reductions
Existing positions increased: 63 | Existing positions reduced: 52
11% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 19
1% more funds holding
Funds holding: 152 → 154 (+2)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
2% less capital invested
Capital invested by funds: $1.53B → $1.5B (-$27.7M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AllianceBernstein
Nashville,
Tennessee
|
+$26.7M |
| 2 |
DM
Deerfield Management
New York
|
+$22.4M |
| 3 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$10.8M |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
+$10.1M |
| 5 |
American Century Companies
Kansas City,
Missouri
|
+$4.58M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
-$24.1M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
-$17.3M |
| 3 |
GIP
Granite Investment Partners
El Segundo,
California
|
-$15M |
| 4 |
Neuberger Berman Group
New York
|
-$6.58M |
| 5 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$5.12M |
SILK Hedge Fund Activity: Q1 2022 in Review
154 of the 6,360 institutional investors tracked by Wall St. Rank reported a position in Silk Road Medical, Inc. Common Stock (SILK) for Q1 2022, worth a combined $1.5B — down 1.8% from $1.53B a quarter earlier.
Buyers outnumbered sellers: 21 funds opened new SILK positions and 19 closed out — a net gain of 2 holders — while 63 added to existing stakes and 52 trimmed.
The largest buyer was AllianceBernstein, adding an estimated $26.7M. The largest seller was Capital World Investors, cutting an estimated $24.1M.
- 154 institutional investors held Silk Road Medical, Inc. Common Stock (SILK) as of Q1 2022, up from 152 in Q4 2021.
- Funds reported $1.5B of Silk Road Medical, Inc. Common Stock stock for Q1 2022, down 1.8% quarter-over-quarter.
- 21 funds opened new Silk Road Medical, Inc. Common Stock positions in Q1 2022 and 19 closed out, a net change of +2 holders.
- The largest Silk Road Medical, Inc. Common Stock buyer in Q1 2022 was AllianceBernstein, an estimated $26.7M added.
- The largest Silk Road Medical, Inc. Common Stock seller in Q1 2022 was Capital World Investors, an estimated $24.1M sold.
Based on aggregated 13F filings for Q1 2022.